Plant‐Derived Treatments for Different Types of Muscle Atrophy
Phytotherapy Research · 2025
DOI: 10.1002/ptr.8420 ↗At a glance
Übersichtsarbeit in Phytotherapy Research, 2025. Written by Xingpeng Wang and 9 co-authors. Institution: Department of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China. Major MEDLINE topics: Muscular Atrophy, Phytotherapy, Plant Extracts. Cited 3 times so far (Crossref); 159 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Shandong Province, Peking Union Medical College Hospital Central High-level Hospital Clinical Research Project, Science Fund for Distinguished Young Scholars of Shandong Province.
Abstract (original language)
With the development of medicine and chemistry, an increasing number of plant‐derived medicines have been shown to exert beneficial therapeutic on the treatment of various physical and psychological diseases. In particular, by using physical chemistry methods, we are able to examine the chemical components of plants and the effects of these substances on the human body. Muscle atrophy (MA) is characterized by decreased muscle mass and function, is caused by multiple factors and severely affects the quality of life of patients. The multifactorial and complex pathogenesis of MA hinders drug research and disease treatment. However, phytotherapy has achieved significant results in the treatment of MA. We searched PubMed and the Web of Science for articles related to plant‐derived substances and muscle atrophy. After applying exclusion and inclusion criteria, 166 and 79 articles met the inclusion criteria, respectively. A total of 173 articles were included in the study after excluding duplicates. The important role of phytoactives such as curcumin, resveratrol, and ginsenosides in the treatment of MA (e.g., maintaining a positive nitrogen balance in muscles and exerting anti‐inflammatory and antioxidant effects) has been extensively studied. Unfortunately, MA dose not have to a single cause, and each cause has its own unique mechanism of injury. This review focuses on the therapeutic mechanisms of active plant components in MA and provides insights into the personalized treatment of MA.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Spine Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
ORCID profiles: Wen Zhang
Funding
- Natural Science Foundation of Shandong Province
- Peking Union Medical College Hospital Central High-level Hospital Clinical Research Project
- Science Fund for Distinguished Young Scholars of Shandong Province
Cite
APA
Wang, X., Tang, X., Wang, Y., Zhao, S., Xu, N., Wang, H., Kuang, M., Han, S., Jiang, Z., & Zhang, W. (2025). Plant‐Derived Treatments for Different Types of Muscle Atrophy. Phytotherapy Research. https://doi.org/10.1002/ptr.8420
Vancouver
Wang X, Tang X, Wang Y, Zhao S, Xu N, Wang H, et al. Plant‐Derived Treatments for Different Types of Muscle Atrophy. Phytotherapy Research. 2025. doi:10.1002/ptr.8420
BibTeX
@article{Wang2025,
author = {Wang, Xingpeng and Tang, Xiaofu and Wang, Yunhui and Zhao, Shengyin and Xu, Ning and Wang, Haoyu and Kuang, Mingjie and Han, Shijie and Jiang, Zhensong and Zhang, Wen},
title = {Plant‐Derived Treatments for Different Types of Muscle Atrophy},
journal = {Phytotherapy Research},
year = {2025},
doi = {10.1002/ptr.8420}
}
EUVIMED